HSBC Holdings’s Altimmune ALT Stock Holding History

HSBC Holdings’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Sell	64,460 -89,905	-58%	-$269K	﹤0.01%	2701
2026 Q1	$476K	Buy	154,365 +22,144	+17%	+$94K	﹤0.01%	2244
2025 Q4	$474K	Buy	132,221 +59,095	+81%	+$258K	﹤0.01%	2346
2025 Q3	$272K	Sell	73,126 -12,342	-14%	-$47.7K	﹤0.01%	2368
2025 Q2	$329K	Buy	85,468 +13,210	+18%	+$71.5K	﹤0.01%	2384
2025 Q1	$349K	Buy	+72,258	New	+$458K	﹤0.01%	2283
2020 Q3	–	Sell	-21,326	Closed	-$228K	–	2712
2020 Q2	$228K	Buy	+21,326	New	+$117K	﹤0.01%	2282
2017 Q1	–	Sell	-36	Closed	-$35K	–	2125
2016 Q4	$35K	Buy	+36	New	+$32.3K	﹤0.01%	2683

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings's ALT Position: Q2 2026 in Review

HSBC Holdings reduced its Altimmune (ALT) stake by 58% in Q2 2026, selling an estimated $269K and leaving 64,460 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

HSBC Holdings first reported a position in ALT in Q4 2016 and has held it in 8 quarters since. The position peaked at $476K in Q1 2026. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

HSBC Holdings held 64,460 shares of Altimmune worth $200K as of Q2 2026.
HSBC Holdings sold 89,905 Altimmune shares in Q2 2026, an estimated $269K.
Altimmune made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2701 holding.
HSBC Holdings first reported a position in Altimmune in Q4 2016 and has held it in 8 quarters since.
HSBC Holdings's Altimmune position peaked at $476K in Q1 2026.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.